Dr. Ece Ergin is a dedicated ophthalmology resident doctor combining clinical care with innovative research. Currently serving at the Emergency University Hospital Bucharest, she is also pursuing her PhD at the “Carol Davila” University of Medicine and Pharmacy. Her work centers around retinal diseases and exploring systemic and ocular biomarkers that can predict treatment responses. Through active participation in research and academic conferences, she demonstrates a strong commitment to advancing patient outcomes and contributing to the medical community. Her ability to bridge research with real-world clinical application defines her as a promising figure in ophthalmology.

EDUCATION

Dr. Ergin’s educational path reflects both academic rigor and focus. She began her early studies at the Cambridge School of Bucharest and pursued medical education at the University of Medicine and Pharmacy “Carol Davila” in Bucharest. She completed her MD in 2023, where she received in-depth training in general and clinical medicine. In 2024, she took a step further by enrolling in a PhD program at the same institution’s Doctoral School, with research aimed at evaluating inflammatory and imaging biomarkers for predicting therapeutic responses in retinal diseases. Her academic foundation sets the stage for a career of impactful medical research and practice.

EXPERIENCE

Since January 2024, Dr. Ergin has been working as an Ophthalmology Resident Doctor at the Emergency University Hospital Bucharest. She is engaged in clinical management of ophthalmic conditions including diabetic macular edema, endophthalmitis, and glaucoma. Her residency also involves training in ophthalmic surgeries, anti-VEGF therapies, and ocular trauma care. In addition to patient care, she has participated in multiple national-level conferences, often as an invited speaker, showcasing her ability to contribute to academic discussions. This blend of clinical exposure and academic activity highlights her well-rounded expertise in the field of ophthalmology.

RESEARCH INTEREST

Dr. Ergin’s research interest focuses on the predictive value of systemic and ocular biomarkers in retinal diseases. Her primary work explores how inflammation-related blood indices and Optical Coherence Tomography (OCT) findings correlate with treatment responsiveness, especially in diabetic macular edema. Her goal is to refine treatment approaches using individualized biomarkers to determine therapeutic outcomes more accurately. This research is both clinically significant and timely, as it addresses the increasing demand for precision medicine in ophthalmology. Through her doctoral research, she aims to contribute new insights to evidence-based retinal disease management.

AWARD

Dr. Ergin has gained recognition through invited presentations and active participation in national academic platforms. She presented her research findings at the 2024 and 2025 Congresses of the Romanian Glaucoma Society, discussing predictors for early treatment effectiveness and case studies involving ocular infections. Her lectures, including one titled “When the Eyes Pay the Price,” were well-received and demonstrated her skill in translating clinical cases into academic discussions. She has also attended specialized workshops and masterclasses, enhancing her surgical knowledge and reinforcing her commitment to continuous learning. These accolades represent acknowledgment of her academic and professional merit.

PUBLICATIONS

Dr. Ergin has co-authored impactful peer-reviewed studies, including two recent publications:

1. Predictive Role of Complete Blood Count-Derived Inflammation Indices and Optical Coherence Tomography Biomarkers for Early Response to Intravitreal Anti-VEGF in Diabetic Macular Edema, published in Biomedicines, 2025; 13(6):1308. This article is cited by studies focusing on personalized treatment protocols for retinal diseases.
2. Effects of the COVID-19 Pandemic on Clinical Manifestations and Therapeutic Outcomes in Acute Endophthalmitis, published in Journal of Mind and Medical Sciences, 2024; 11(2):475–481. This work has been cited in literature addressing ophthalmic complications in infectious disease contexts.

These publications emphasize her role in contributing meaningful data to the field and improving clinical practices.

CONCLUSION

Dr. Ece Ergin exemplifies the emerging generation of clinician-researchers whose work bridges patient care and medical innovation. Her academic achievements, research contributions, and active involvement in ophthalmic education position her as an outstanding candidate for award recognition. Through her residency and doctoral studies, she continues to advance in both science and service. With a focus on individualized treatment approaches and a dedication to lifelong learning, Dr. Ergin stands out as a promising and impactful contributor to the future of ophthalmology.